New Findings from National Cancer Institute (NCI) in Carcinomas Provides New Insights (Nivolumab Plus Ipilimumab Plus Cabozantinib Triplet Combination for Patients With Previously Untreated Advanced Renal Cell Carcinoma: Results From a ...)

Press/Media

Period23 Dec 2022

Media coverage

1

Media coverage

  • TitleNew Findings from National Cancer Institute (NCI) in Carcinomas Provides New Insights (Nivolumab Plus Ipilimumab Plus Cabozantinib Triplet Combination for Patients With Previously Untreated Advanced Renal Cell Carcinoma: Results From a ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date23/12/22
    URLct.moreover.com/?a=49581819124&p=1gw&v=1&x=C599B_rjzYzQMsZauNM5zw
    PersonsMauricio Burotto
View all 1
View less

Related content